注册 | 登录 | 充值

首页-> 学术资讯 -> 文献解读

AnnSurg:肿瘤切除一年后持续循环的肿瘤细胞预测胰腺癌的晚期复发

文献解读

2022-09-26      

981 0


该研究的目的是评估持续性 CTC 与术后约 12 个月临床无复发的患者随后复发之间的关联。

循环肿瘤细胞已被提议作为预测胰腺癌存活率的生物标志物。一些患者在术后表现出持续的 CTC,这可能代表最小的残留病灶。


来自先前发表的前瞻性 CLUSTER 试验的患者在术后 12 个月没有临床复发证据,并且在术后 9-15 个月进行了 CTC 检测。上皮细胞 (eCTC) 和移行细胞 (trCTC) 的存在被评估为复发的预测因子。 Kaplan-Meier曲线、对数秩检验和Cox模型用于生存分析。


纳入了 129 名符合条件的患者中的 33 名(CLUSTER 试验)。 trCTC 阳性和阴性患者的临床病理特征平衡良好。 trCTCs 患者的每人每月复发率为 10.3%,而 trCTCs 阴性患者的复发率为 3.1%,中位复发时间分别为 3.9 个月和 27.1 个月。在多变量分析中,trCTCs 阳性与较高的晚期复发风险相关(HR:4.7,95%CI:1.2-18.3,P=0.024)。 14 名 (42.4%) 患者在术后第二年复发。术后 1 年 trCTCs 阳性与第二年较高的复发率相关(OR:13.1,95%CI:1.6-1953.4,P=0.028,AUC=0.72)。将临床病理学特征与 trCTC 相结合将 AUC 增加到 0.80。大多数 trCTCs 阳性患者(N=5, 62.5%)有多部位复发,其次是仅局部(N=2, 25.0%)和仅肝脏(N=1, 12.5%)复发。这与 trCTCs 阴性患者形成鲜明对比,其中大多数(N=6, 66.7%)仅局部复发,其次是仅肝脏(N=2, 22.2%)和多部位(N=1, 11.1%) 复发。在术后 12 个月被认为临床无病的患者中,trCTCs 阳性与更高的随后复发率相关,且复发模式不同。 CTC 可用作推定的生物标志物来指导胰腺癌患者的预后和管理。


Abstract

Objective: The aim of the study was to assess the association between persistent CTCs and subsequent recurrence in patients who were clinically recurrence free approximately 12 months postoperatively.


Background: Circulating tumor cells have been proposed as biomarkers to predict survival in pancreatic cancer. Some patients demonstrate persistent CTCs postoperatively which could represent minimal residual disease.


Methods: Patients from previously published prospective CLUSTER trial without clinical evidence of recurrence 12 months postoperatively and CTC testing performed 9-15 months postoperatively were included. Presence of epithelial (eCTCs) and transitional CTCs (trCTCs) was evaluated as predictor of recurrence. Kaplan-Meier curve, log-rank test, and Cox model were used for survival analysis.


Results: Thirty-three of 129 eligible patients (CLUSTER trial) were included. The trCTC positive and negative patients were well-balanced in clinicopathological features. Patients with trCTCs had a recurrence rate per-person-month of 10.3% compared to 3.1% in trCTCs negative patients with a median time to recurrence of 3.9 versus 27.1 months, respectively. On multivariable analysis trCTCs positivity was associated with higher risk of late recurrence (HR:4.7,95%CI:1.2-18.3, P=0.024). Fourteen (42.4%) patients recurred during the second postoperative year. 1-year postoperative trCTCs positivity was associated with a higher rate of recurrence during the second year (OR:13.1,95%CI:1.6-1953.4,P=0.028, AUC=0.72). Integrating clinicopathological features with trCTCs increased the AUC to 0.80. A majority of trCTCs positive patients (N=5, 62.5%) had multi-site recurrence, followed by local-only (N=2, 25.0%) and liver-only (N=1, 12.5%) recurrence. This was in striking contrast to trCTCs negative patients, where a majority (N=6, 66.7%) had a local-only recurrence, followed by liver-only (N=2, 22.2%) and multi-site (N=1, 11.1%) recurrence.


Conclusion: In patients deemed to be clinically disease free 12 months postoperatively, trCTCs positivity is associated with higher rates of subsequent recurrence with distinct patterns of recurrence. CTCs could be used a putative biomarker to guide patient prognostication and management in pancreatic cancer.


原文链接

https://pubmed.ncbi.nlm.nih.gov/36111892/



科研资讯(站内):

百度浏览   来源 : 医微客   


版权声明:本网站所有注明来源“医微客”的文字、图片和音视频资料,版权均属于医微客所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源:”医微客”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,转载仅作观点分享,版权归原作者所有。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。 本站拥有对此声明的最终解释权。

科研搜索(百度):医学科研





发表评论

注册或登后即可发表评论

登录注册

全部评论(0)

没有更多评论了哦~

科研资讯 更多>>
  • Nature子刊:涂毅恒团队揭示慢性..
  • Nature重磅:只需一针,让免疫系..
  • 刚刚!院外送检!卫健委点名!..
  • 脂肪肝到肝癌,只需要4步!每天..
  • 推荐阅读 更多>>
  • GYNECOL ONCOL:早期宫颈癌的实..
  • thebmj:妊娠期糖尿病与特异性心..
  • thebmj:评估19个国家儿童和青少..
  • thebmj:妊娠期糖尿病患者和2型..
    • 相关阅读
    • 热门专题
    • 推荐期刊
    • 学院课程
    • 医药卫生
      期刊级别:国家级期刊
      发行周期:暂无数据
      出版地区:其他
      影响因子:暂无数据
    • 中华肿瘤
      期刊级别:北大核心期刊
      发行周期:月刊
      出版地区:北京
      影响因子:1.90
    • 中华医学
      期刊级别:CSCD核心期刊
      发行周期:周刊
      出版地区:北京
      影响因子:0.94